Industry News
Luminex licensed technologies partner spotlight: Wageningen prime diagnostics
Multiplex molecular testing for plant pathogens
News & Articles
25
Selected Filters:
Industry News
Luminex submits joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA
The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target
Product News
Luminex files for emergency use of expanded NxTAG Respiratory Panel test
Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season
Industry News
Luminex receives FDA emergency use authorization for COVID-19 antibody test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
Industry News
Luminex receives FDA emergency use authorization for COVID-19 diagnostic panel
Recent funding from the BARDA award helped the company accelerate development and validation
Product News
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay
Commercially available xMAP® MultiFLEX™ Zika RNA assay, designed by GenArraytion, Inc., detects 6 genetic targets of Zika virus
Product News
Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus
PCR-based Assay Runs on the ARIES® System, a Sample to Answer Platform
Editorial Article
Research into Early Detection of Biomarkers in Alzheimer’s Disease
written by Luminex
Editorial Article
Development of a Luminex xMAP® Assay to Detect Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid
written by Luminex
